Cargando…

Flavopiridol (Alvocidib), a Cyclin-dependent Kinases (CDKs) Inhibitor, Found Synergy Effects with Niclosamide in Cutaneous T-cell Lymphoma

Flavopiridol (FVP; Alvocidib), a CDKs inhibitor, is currently undergoing clinical trials for treatment of leukemia and other blood cancers. Our studies demonstrated that FVP also inhibited p38 kinases activities with IC(50) (μM) for p38α: 1.34; p38 β: 1.82; p38γ: 0.65, and p38δ: 0.45. FVP showed pot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xu Hannah, Hsiang, Jack, Rosen, Steven T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8248901/ https://www.ncbi.nlm.nih.gov/pubmed/34223559 http://dx.doi.org/10.33696/haematology.2.028

Ejemplares similares

The cyclin-dependent kinase inhibitor flavopiridol (alvocidib) inhibits metastasis of human osteosarcoma cells
por: Zocchi, Loredana, et al.
Publicado: (2018)

The Emerging Role of Cyclin-Dependent Kinases (CDKs) in Pancreatic Ductal Adenocarcinoma
por: García-Reyes, Balbina, et al.
Publicado: (2018)

Cyclins and CDKs in the regulation of meiosis-specific events
por: Palacios-Blanco, Inés, et al.
Publicado: (2022)

Therapeutic Potential of the Cyclin-Dependent Kinase Inhibitor Flavopiridol on c-Myc Overexpressing Esophageal Cancer
por: Hassan, Md Sazzad, et al.
Publicado: (2021)

Antitumor effects of flavopiridol, a cyclin-dependent kinase inhibitor, on human cholangiocarcinoma in vitro and in an in vivo xenograft model
por: Saisomboon, Saowaluk, et al.
Publicado: (2019)

Complexes of D-type cyclins with CDKs during maize germination
por: Godínez-Palma, Silvia K., et al.
Publicado: (2013)

Flavopiridol Mitigates the Progression of Monocrotaline-Induced Pulmonary Hypertension in Rats by Targeting Cyclin-Dependent Kinase 9
por: Jia, Qi, et al.
Publicado: (2022)

Risk Factors for Tumor Lysis Syndrome in patients with Chronic Lymphocytic Leukemia Treated with the Cyclin Dependent Kinase Inhibitor, Flavopiridol
por: Blum, Kristie A., et al.
Publicado: (2011)

Combined venetoclax and alvocidib in acute myeloid leukemia
por: Bogenberger, James, et al.
Publicado: (2017)

The angiogenic properties of Kaposi's sarcoma-associated herpesvirus encoded G-protein coupled receptor are reduced by flavopiridol, an inhibitor of cyclin-dependent kinase 9
por: McFerrin, Harris, et al.
Publicado: (2010)

Modulation of Primary Cilia by Alvocidib Inhibition of CILK1
por: Wang, Elena X., et al.
Publicado: (2022)

Comparative genomics of cyclin-dependent kinases suggest co-evolution of the RNAP II C-terminal domain and CTD-directed CDKs
por: Guo, Zhenhua, et al.
Publicado: (2004)

For cdks, one is enough
por: Leslie, Mitch
Publicado: (2007)

B-Cyclin/CDKs Regulate Mitotic Spindle Assembly by Phosphorylating Kinesins-5 in Budding Yeast
por: Chee, Mark K., et al.
Publicado: (2010)

Study on the Interactions of Cyclins with CDKs Involved in Auxin Signal during Leaf Development by WGCNA in Populus alba
por: Liang, Jinghui, et al.
Publicado: (2023)

Potent interaction of flavopiridol with MRP1
por: Hooijberg, J H, et al.
Publicado: (1999)

Effect of P-glycoprotein on flavopiridol sensitivity
por: Boerner, S A, et al.
Publicado: (2001)

The Pharmacological Implications of Flavopiridol: An Updated Overview
por: Joshi, Hemant, et al.
Publicado: (2023)

Cdks set the replication schedule
por: Leslie, Mitch
Publicado: (2010)

A CRISPR knockout negative screen reveals synergy between CDKs inhibitor and metformin in the treatment of human cancer in vitro and in vivo
por: Ma, Yarui, et al.
Publicado: (2020)

Cyclin-Dependent Kinases (CDKs) and the Human Cytomegalovirus-Encoded CDK Ortholog pUL97 Represent Highly Attractive Targets for Synergistic Drug Combinations
por: Wild, Markus, et al.
Publicado: (2022)

Alvocidib inhibits IRF4 expression via super‐enhancer suppression and adult T‐cell leukemia/lymphoma cell growth
por: Sakamoto, Hikaru, et al.
Publicado: (2022)

Transgenic models are predictive: the herceptin and flavopiridol experience
por: Schmidt, E
Publicado: (2003)

The Role of CDKs and CDKIs in Murine Development
por: Campbell, Grace Jean, et al.
Publicado: (2020)

Flavopiridol Pharmacogenetics: Clinical and Functional Evidence for the Role of SLCO1B1/OATP1B1 in Flavopiridol Disposition
por: Ni, Wenjun, et al.
Publicado: (2010)

Complex effects of flavopiridol on the expression of primary response genes
por: Keskin, Havva, et al.
Publicado: (2012)

Venetoclax and alvocidib are both cytotoxic to acute myeloid leukemia cells resistant to cytarabine and clofarabine
por: Nishi, Rie, et al.
Publicado: (2020)

Inhibition of Cyclin-dependent Kinase (CDK) Decreased Survival of NB4 Leukemic Cells: Proposing a p53-Independent Sensitivity of Leukemic Cells to Multi-CDKs Inhibitor AT7519
por: Pourbagheri-Sigaroodi, Atieh, et al.
Publicado: (2020)

Cdks put Treslin on TopBP1
por: Short, Ben
Publicado: (2011)

Fueling the Cycle: CDKs in Carbon and Energy Metabolism
por: Solaki, Maria, et al.
Publicado: (2018)

CDKs in Sarcoma: Mediators of Disease and Emerging Therapeutic Targets
por: Kohlmeyer, Jordan L, et al.
Publicado: (2020)

Targeting the non‐ATP‐binding pocket of the MAP kinase p38γ mediates a novel mechanism of cytotoxicity in cutaneous T‐cell lymphoma (CTCL)
por: Zhang, Xu Hannah, et al.
Publicado: (2021)

Mitochondrial Priming of Chronic Lymphocytic Leukemia Patients Associates Bcl-x(L) Dependence with Alvocidib Response
por: Pierceall, William E., et al.
Publicado: (2014)

Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan
por: Ikezoe, Takayuki, et al.
Publicado: (2022)

Flavopiridol Protects Bone Tissue by Attenuating RANKL Induced Osteoclast Formation
por: Hu, Zi’ang, et al.
Publicado: (2018)

Controlling DNA-end resection: a new task for CDKs
por: Ferretti, Lorenza P., et al.
Publicado: (2013)

Plant CDKs—Driving the Cell Cycle through Climate Change
por: Carneiro, Aline Köhn, et al.
Publicado: (2021)

An Inhibitor’s-Eye View of the ATP-Binding Site of CDKs in Different Regulatory States
por: Echalier, Aude, et al.
Publicado: (2014)

Growth dynamics and cyclin expression in cutaneous T-cell lymphoma cell lines
por: Biskup, Edyta, et al.
Publicado: (2010)

Potent inhibition of rhabdoid tumor cells by combination of flavopiridol and 4OH-tamoxifen
por: Cimica, Velasco, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_eaec8cr0t9f2aae6vqa4k5nnlq